
ACT Brief: China’s Startup Timelines, AI-Drafted Clinical Study Reports, and Bimzelx Psoriatic Arthritis Data
10.11.2026
0:00
1:47
In today’s ACT Brief, we examine how China’s trial startup timelines compare with those in the US and Europe, whether AI-drafted clinical study reports speed drug development, and how Bimzelx compared with Skyrizi in psoriatic arthritis.
Weitere Episoden von „Applied Clinical Trials“



Verpasse keine Episode von “Applied Clinical Trials” und abonniere ihn in der kostenlosen GetPodcast App.








